50 related articles for article (PubMed ID: 8606530)
1. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
Edvinsson L; Nilsson E; Jansen-Olesen I
Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
[TBL] [Abstract][Full Text] [Related]
2. Vascular reactivity to calcitonin gene-related peptide is enhanced in subtotal nephrectomy-salt induced hypertension.
Supowit SC; Katki KA; Hein TW; Gupta P; Kuo L; Dickerson IM; Dipette DJ
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H683-8. PubMed ID: 21666123
[TBL] [Abstract][Full Text] [Related]
3. A pancreatic player in dementia: pathological role for islet amyloid polypeptide accumulation in the brain.
Bortoletto AS; Parchem RJ
Neural Regen Res; 2023 Oct; 18(10):2141-2146. PubMed ID: 37056121
[TBL] [Abstract][Full Text] [Related]
4. Association of Plasma Amylin Concentration With Alzheimer Disease and Brain Structure in Older Adults.
Zhu H; Tao Q; Ang TFA; Massaro J; Gan Q; Salim S; Zhu RY; Kolachalama VB; Zhang X; Devine S; Auerbach SH; DeCarli C; Au R; Qiu WQ
JAMA Netw Open; 2019 Aug; 2(8):e199826. PubMed ID: 31433485
[TBL] [Abstract][Full Text] [Related]
5. An amylin analog used as a challenge test for Alzheimer's disease.
Zhu H; Stern RA; Tao Q; Bourlas A; Essis MD; Chivukula M; Rosenzweig J; Steenkamp D; Xia W; Mercier GA; Tripodis Y; Farlow M; Kowall N; Qiu WQ
Alzheimers Dement (N Y); 2017 Jan; 3(1):33-43. PubMed ID: 28503657
[TBL] [Abstract][Full Text] [Related]
6. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
[TBL] [Abstract][Full Text] [Related]
7. Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
Wang E; Zhu H; Wang X; Gower AC; Wallack M; Blusztajn JK; Kowall N; Qiu WQ
J Alzheimers Dis; 2017; 56(1):47-61. PubMed ID: 27911303
[TBL] [Abstract][Full Text] [Related]
8. Amylin at the interface between metabolic and neurodegenerative disorders.
Lutz TA; Meyer U
Front Neurosci; 2015; 9():216. PubMed ID: 26136651
[TBL] [Abstract][Full Text] [Related]
9. Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment.
Qiu WQ; Li H; Zhu H; Scott T; Mwamburi M; Rosenberg I; Rosenzweig J
J Diabetes Metab; 2014 Nov; 5(11):. PubMed ID: 25750761
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin.
Srodulski S; Sharma S; Bachstetter AB; Brelsfoard JM; Pascual C; Xie XS; Saatman KE; Van Eldik LJ; Despa F
Mol Neurodegener; 2014 Aug; 9():30. PubMed ID: 25149184
[TBL] [Abstract][Full Text] [Related]
11. Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
Qiu WQ; Zhu H
Front Aging Neurosci; 2014; 6():186. PubMed ID: 25120481
[TBL] [Abstract][Full Text] [Related]
12. Positive association between plasma amylin and cognition in a homebound elderly population.
Qiu WQ; Au R; Zhu H; Wallack M; Liebson E; Li H; Rosenzweig J; Mwamburi M; Stern RA
J Alzheimers Dis; 2014; 42(2):555-63. PubMed ID: 24898659
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
Zhu H; Wang X; Wallack M; Li H; Carreras I; Dedeoglu A; Hur JY; Zheng H; Li H; Fine R; Mwamburi M; Sun X; Kowall N; Stern RA; Qiu WQ
Mol Psychiatry; 2015 Feb; 20(2):252-62. PubMed ID: 24614496
[TBL] [Abstract][Full Text] [Related]
14. Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.
Qiu WQ; Wallack M; Dean M; Liebson E; Mwamburi M; Zhu H
PLoS One; 2014; 9(2):e88063. PubMed ID: 24520345
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.
Wiley KE; Davenport AP
Br J Pharmacol; 2002 Aug; 136(8):1146-52. PubMed ID: 12163347
[TBL] [Abstract][Full Text] [Related]
16. Amylin-induced relaxation of the perfused mesenteric arterial bed: meditation by calcitonin gene-related peptide receptors.
Westfall TC; Curfman-Falvey M
J Cardiovasc Pharmacol; 1995 Dec; 26(6):932-6. PubMed ID: 8606530
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors.
Chin SY; Hall JM; Brain SD; Morton IK
J Pharmacol Exp Ther; 1994 Jun; 269(3):989-92. PubMed ID: 8014885
[TBL] [Abstract][Full Text] [Related]
18. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CGRP(1) receptors in the guinea pig basilar artery.
Jansen-Olesen I; Kaarill L; Edvinsson L
Eur J Pharmacol; 2001 Mar; 414(2-3):249-58. PubMed ID: 11239926
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
